A2A PharmaFeb 7A2A / Daewoong Pharmaceutical Oncology Agreement A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology Drug Discovery.LEARN MORE
A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology Drug Discovery.LEARN MORE
A2A PharmaOct 2, 2019A2A Appoints New AdvisorsDr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE
Dr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE
A2A PharmaJul 1, 2019A2A Pharmaceuticals Appoints CEOUpdated: Feb 7 A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive OfficerLEARN MORE
.png)